Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC‐MS/MS
- 16 July 2013
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 34 (19), 2910-2917
- https://doi.org/10.1002/elps.201300029
Abstract
Hepatitis C virus (HCV) infection of the liver is a global health problem and a major risk factor for the development of hepatocellular carcinoma (HCC). Sensitive methods are needed for the improved and earlier detection of HCC, which would provide better therapy options. Metabolic profiling of the high‐risk population (HCV patients) and those with HCC provides insights into the process of liver carcinogenesis and possible biomarkers for earlier cancer detection. Seventy‐three blood metabolites were quantitatively profiled in HCC (n = 30) and cirrhotic HCV (n = 22) patients using a targeted approach based on LC‐MS/MS. Sixteen of 73 targeted metabolites differed significantly (p < 0.05) and their levels varied up to a factor of 3.3 between HCC and HCV. Four of these 16 metabolites (methionine, 5‐hydroxymethyl‐2′‐deoxyuridine, N2,N2‐dimethylguanosine, and uric acid) that showed the lowest p values were used to develop and internally validate a classification model using partial least squares discriminant analysis. The model exhibited high classification accuracy for distinguishing the two groups with sensitivity, specificity, and area under the receiver operating characteristic curve of 97%, 95%, and 0.98, respectively. A number of perturbed metabolic pathways, including amino acid, purine, and nucleotide metabolism, were identified based on the 16 biomarker candidates. These results provide a promising methodology to distinguish cirrhotic HCV patients, who are at high risk to develop HCC, from those who have already progressed to HCC. The results also provide insights into the altered metabolism between HCC and HCV.Keywords
This publication has 41 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite ProfilingMetabolites, 2012
- Natural history of acute and chronic hepatitis CBest Practice & Research Clinical Gastroenterology, 2012
- Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma DiagnosisMolecular & Cellular Proteomics, 2012
- Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid ProfilingCancer Research, 2011
- Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic methodAnalytical and Bioanalytical Chemistry, 2011
- Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular CarcinomaMolecular & Cellular Proteomics, 2011
- Early Detection of Recurrent Breast Cancer Using Metabolite ProfilingCancer Research, 2010
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injuryJCI Insight, 2008